CIBC World Markets’s Evolus EOLS Stock Holding History

CIBC World Markets’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-12,406	Closed	-$149K	–	1676
2025 Q1	$149K	Buy	+12,406	New	+$162K	﹤0.01%	1534

Other funds holding EOLS

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CIBC World Markets's EOLS Position: Q2 2025 in Review

CIBC World Markets sold out of Evolus (EOLS) in Q2 2025, closing a stake of 12,406 shares — an estimated $149K sold.

CIBC World Markets first reported a position in EOLS in Q1 2025 and held it in 1 quarter. The position peaked at $149K in Q1 2025. 172 funds tracked by Wall St. Rank hold EOLS as of Q2 2025.

CIBC World Markets reported no remaining Evolus position as of Q2 2025 after selling out during the quarter.
CIBC World Markets sold 12,406 Evolus shares in Q2 2025, an estimated $149K.
CIBC World Markets first reported a position in Evolus in Q1 2025 and held it in 1 quarter.
CIBC World Markets's Evolus position peaked at $149K in Q1 2025.
172 funds tracked by Wall St. Rank held Evolus as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.